JAIDS Journal of Acquired Immune Deficiency Syndromes:
Epidemiology and Prevention
Sexual Behaviors Over a 3-Year Period Among Individuals With Advanced HIV/AIDS Receiving Antiretroviral Therapy in an Urban HIV Clinic in Kampala, Uganda
Wandera, Bonnie MBChB, MS*; Kamya, Moses R MBChB, MMed, MPH PhD†; Castelnuovo, Barbara MD*; Kiragga, Agnes MSc*; Kambugu, Andrew MBChB, MMed*; Wanyama, Jane N RN, BCP*; Easterbrook, Philippa MB, BChir, FRCP, MPH*; Sethi, Ajay K PhD, MHS‡
From the *Infectious Diseases Institute, Kampala, Uganda; †Department of Medicine, Makerere University, Kampala, Uganda; and ‡Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Received for publication September 21, 2010; accepted January 20, 2011.
Funded in part by the International Clinical, Operational and Health Services Research in Tuberculosis and AIDS (ICOHRTA) training program at Case Western Reserve University (TW006900) (to B.W.) and the Academic alliance for AIDS Care and prevention in Africa (now ACCORDIA).
Presented in part at the 5th International Conference on HIV pathogenesis treatment and prevention, July 19-22, 2009, Cape Town South Africa.
The authors have no conflicts of interest to disclose.
Correspondence to: Bonnie Wandera, MBChB, MS, Infectious Diseases Institute, PO Box 22418, Kampala, Uganda (e-mail: email@example.com).
Background: Few studies have prospectively examined sexual behaviors of HIV-infected person on antiretroviral therapy (ART) in sub-Saharan Africa.
Methods: Between 2004 and 2005, 559 HIV-infected, ART-naïve individuals initiating ART at an HIV clinic in Kampala, Uganda, were enrolled into a prospective study and followed to 2008. Clinical and sexual behavior information was assessed at enrollment and semiannually for 3 years after ART initiation. Using log-binomial regression models, we estimated prevalence ratios (PRs) to determine factors associated with being sexually active and having unprotected sex over 3 years after initiating ART.
Results: Five hundred fifty-nine adults contributed 2594 person-visits of follow-up. At the time of ART initiation, 323 (57.9%) were sexually active of which 176 (54.5%) had unprotected sex at last sexual intercourse. The majority (63.4%) of married individuals were unaware of their partner's HIV status. Female gender (PR, 2.97; 95% confidence interval, 1.85-4.79), being married (PR, 1.48; 95% confidence interval, 1.06-2.06), and reporting unprotected sex before ART (PR, 1.68; 95% confidence interval, 1.16-2.42) were among the factors independently associated with unprotected sex while on ART. Overall, 7.3% of visit intervals of unprotected sex, 1.0% of intervals of sexual activity, occurred when plasma viral load greater than 1500 copies/mL, representing periods of greater HIV transmission risk.
Conclusions: Although unprotected sex reduced over time, women reported unprotected sex more often than men. Disclosure of HIV status was low. Integration of comprehensive prevention programs into HIV care is needed, particularly ones specific for women.
In both resourced and resource-limited settings, effective antiretroviral therapy (ART) for HIV infection leads to increased survival, decreased morbidity, and improved quality of life in treated individuals.1-7 ART is associated with return of sexual desire and sexual activity.8,9 Furthermore, lowered perceived infectiousness in persons with undetectable plasma viral load may lead to increased high-risk sexual behaviors such as unprotected sexual intercourse and having multiple sexual partners.10,11
Studies of sexual behaviors while on ART are mainly from the developed countries, consisting mainly men who have sex with men and other populations whose sexual culture and practices are different from those in sub-Saharan Africa.12,13 Relatively fewer studies are published from sub-Saharan Africa where HIV transmission is mainly the result of heterosexual sex, women are disproportionately affected, and ART is often initiated at an advanced stage of HIV disease when plasma HIV RNA concentration and, thus, infectiousness is high.14 Therefore, we examined the prevalence of and factors associated with sexual activity, unprotected sex, and having multiple sexual partners among HIV-infected adults before and up to 3 years after initiating ART in an urban HIV clinic in Kampala, Uganda, that had free condoms available.
Study Setting and Population
As described previously, between April 2004 and April 2005, HIV-infected, ART-naïve adults aged at least 18 years were enrolled in a prospective study at the Adult Infectious Diseases Clinic in Kampala, Uganda, to describe responses to ART.15 ART was initiated based on the Uganda Ministry of Health guidelines, which were adapted from the World Health Organization (WHO) guidelines for resource-limited settings.16 In addition to cotrimoxazole prophylaxis, subjects received either a nevirapine- or efavirenz-containing regimen with a backbone of lamivudine with either stavudine or zidovudine. Counseling on nutrition, ART adherence, safer reproductive health, and contraception, including provision of male condoms, was also provided. Clients were informed that if they were to have sex, regardless of their partners' HIV status, they needed to use a condom to prevent transmission of HIV and other sexually transmitted infections.
Study Assessments and Follow-Up
Study visits were conducted at enrollment and every 3 months for clinical evaluations. For every 6 months up until 3 years of ART (April 2008), laboratory evaluation, sociodemographics, sexual behaviors during the previous 6 months, and knowledge/beliefs about ART and HIV transmission by a trained nurse-counselor, through a structured interviewer-administered questionnaire in either English or Luganda (a local vocabulary) was conducted. Participants were classified as being currently married if they reported being married or cohabiting and as unmarried if they were single, widowed, or divorced. Participants were considered sexually active if they had had sex in the previous 6 months, to have engaged in unprotected sex if they did not use a condom the last time they had sex, and to have multiple partners if they had engaged in sexual activity with two or more people in the previous 12 months.
Clinical status was recorded using WHO clinical stage and Karnofsky performance score. CD4+ T cell count was enumerated by FACS Count (Becton Dickinson, San Jose, CA) for the first year and later by FACS Calibur (Becton Dickinson). Plasma HIV RNA concentration was determined by the Amplicor HIV-1 Monitor PCR Test Version 1.5 (Roche Diagnostics, Indianapolis, IN) with a lower limit of detection of 400 copies/mL. CD4 and viral load were made available to providers to monitor response to ART and manage HIV care according to WHO guidelines at the time. The study was approved by the Institutional Review Board of Makerere University and the Uganda National Council of Science and Technology.
The proportions of subjects reporting sexual activity, unprotected sex and having multiple partners at the time of ART initiation, the baseline visit, were estimated. Pearson chi-square and Wilcoxon rank sum tests were used to examine categorical and nonnormally distributed continuous factors associated with these sexual behaviors, respectively. Trends in high-risk sexual behavior over time were examined using Pearson chi-square test.
Factors associated with being sexually active and the occurrence of unprotected sex among sexually active adults over 3 years after ART initiation were modeled using log-binomial models with a robust variance estimator using a modified Poisson approach.17 Log-binomial regression yields the prevalence ratio (PR) and chosen over standard logistic regression because the PR is a better estimator of the relative risk than is the odds ratio when outcomes of interest are not rare. Given that the data represented a period cross-section with multiple observations per individual, we used marginal generalized estimating equations with a log link function, an unstructured correlation structure, and robust variance estimation. Factors whose association with the dependent variable were statistically suggestive (P < 0.2) in univariable analysis or were conceptually important were entered into a multivariable model. Variables retained in the final models were age and those that were independently associated with unprotected sex.
To highlight the potential for further sexual transmission of HIV and possible drug-resistant virus, we examined the prevalence of unprotected sex among participants with at least two consecutive visits with plasma HIV RNA concentration above 1500 copies/mL after ART initiation. We used a cutoff of 1500 copies/mL as a result of the very low transmission risk below this level.18 Statistical analyses were conducted using SAS Version 9.2 (SAS Institute Inc, Cary, NC).
A total of 559 ART-naïve, HIV-infected individuals were enrolled at the time of initiation of first-line ART. The majority, 494 of 559 (88.4%), had advanced HIV/AIDS with WHO clinical Stage III or IV disease (Table 1). The median (interquartile range) age, CD4+ T cell count, and log10 plasma HIV RNA were 38 (33-44) years, 98 (21-166) cells/mm3, and 5.4 (5.1-5.8), respectively. Three hundred eighty-five (68.9%) were women and 261 (46.7%) were married or cohabiting. Among married/cohabitating persons, one third (n = 78) had a confirmed HIV-infected partner, whereas 16 (6.1%) had an HIV-uninfected partner. The majority, 163 (63.4%), were unaware of their partner's HIV status.
Preantiretroviral Treatment Sexual Behaviors
A total of 323 (57.8%) individuals reported sexual intercourse within the 6 months preceding ART initiation (Table 1). Among those who were sexually active, 54.5% (176 of 323) reported unprotected sex at their last sexual encounter. Overall, 70 (12.6%) reported having more than two sexual partners in the previous 12 months. Ninety-two (28.5%) reported that their last sexual encounter was with a nonregular partner.
Being sexually active and having more than two sexual partners in the previous year were reported by higher proportions of men, the employed, and those with greater monthly household income. Among sexually active adults, unprotected sex was reported more often by women, unmarried individuals, and those with lower income, although the latter was the only one that achieved statistical significance. Although clinical factors (WHO HIV clinical stage, baseline CD4+ T cell count, Karnofsky score, and duration of HIV positivity) were not associated with being sexual active, unprotected sex among sexually active adults was more often reported by those with advanced HIV disease and lower Karnofsky performance score.
Of the 559 subjects enrolled, 472 (84.4%) returned for at least one follow-up visit contributing 2594 person-visits. A total of 399 (71.4%) returned for all the six follow-up visits. Of the 160 subjects followed for less than 3 years, 99 (62%) had died with 78 of 99 (78.8%) deaths resulting from AIDS-associated opportunistic infections mainly within the first 3 months of ART.19 Thirty-three (5.9%) individuals were lost to follow-up, whereas 26 withdrew from the study because they transferred their HIV care to outside the clinic catchment area.19 There were no statistically significant differences in losses to follow-up by age, gender, marital status, baseline plasma HIV RNA concentration, or baseline sexual behavior condom use.
Sexual Behaviors After Antiretroviral Treatment Initiation
Sexual behavior data were available for 92.4% of person-visits (2327 of 2594). Sexual intercourse was reported at 1189 (51.1%) person-visits and unprotected sex at the last intercourse was reported at 14.6% (174 of 1189) of person-visits. The proportion of subjects reporting sexual intercourse decreased in the first 6 months after ART initiation from 58% to 50% but remained steady over the subsequent 2 years at an average of 51% (P = 0.911; Fig. 1). Among sexually active subjects, unprotected sex decreased over the first 12 months on ART from 53% to 15% and stabilized thereafter at approximately 11.5% over the next 2 years of the study (P = 0.348). The proportion of subjects reporting two or more sexual partners declined from baseline level of 18.3% to an average of 9.2% at the first follow-up visit and remained constant at an average proportion of 9.0% over the next 2.5 years (P = 0.829). Thirty-eight (9.8%) women became pregnant during the study period.
In multivariable analysis, factors independently associated with being sexually active while on ART were being married and reporting sexual activity at the time of ART initiation (Table 2). Female gender, lower household income, and believing that HIV-infected persons should abstain from sexual intercourse were independently associated with not being sexually active while on ART.
Being a woman, being unmarried, having a lower household income, reporting unprotected sex at the time of ART initiation, having no children, and believing that ART reduced the risk of HIV transmission were independently associated with higher prevalence of unprotected sex in the adjusted analysis. Although women receiving ART were less sexually active than men, those who engaged in sexual intercourse were three times more likely than men to report unprotected sex in multivariable analysis. There was a statistically significant interaction between gender and time on ART. As compared with sexually active men, the relative proportion of women reporting unprotected sex increased over time (PR, 1.72, 2.14, 5.12, 7.09, and 6.20 for 0.5, 1.0, 1.5, 2.0, and 3.0 years on ART, respectively). At study Visit 5 (2.5 years after ART), none of the men interviewed reported unprotected sex. The interaction term was not retained in the final multivariable model because it did not confound other variables.
Unprotected Sex and Detectable Plasma HIV RNA Concentration
Plasma HIV RNA concentration was recorded at 96.8% (2512 of 2594) of visit pairs after ART initiation and sexual behavior data during the interval enclosed by these visit pairs were available at 89.8% (2257 of 2512) of visit pairs. Sexual activity was reported during 1152 (51.0%) of these intervals and unprotected sex occurred during 14.2% (164 of 1152) of these intervals of sexual activity. Overall, in 7.3% (12 of 164) of intervals of unprotected sex, 1.0% (12 of 1152) of intervals of sexual activity occurred during a period when plasma viral load was greater than 1500 copies/mL, representing periods of higher risk for HIV transmission; most (10 of 12 [83.3%]) of these occurred within the first year after ART initiation.
The median (interquartile range) viral load at the visit preceding the unprotected sexual event was 5.19 (4.69-5.43) log10 copies/mL, whereas that recorded at the evaluation visit was 5.21 (4.46-5.34) log10 copies/mL. Sexually active individuals with a plasma viral load greater than 1500 copies/mL despite being on ART for at least 6 months (ie, evidence of possibly failing treatment) were not more likely to have reported high-risk sex (unprotected sex or having multiple sex partners; PR, 1.12; 95% confidence interval, 0.66-1.91).
Despite the advanced HIV disease and very low baseline CD4+ T cell counts, 58% of subjects were sexually active, over half of whom had unprotected sex, at ART initiation. Over 3 years of ART, we observed no increase in sexual activity and a significant decrease in reported unprotected sex and multiple sex partners.
Our study conducted in a clinic in Kampala, Uganda, is similar to those from North America and Western Europe, which also demonstrated that receiving ART is not associated with increased sexual risk behaviors.12 Similarly, a study of HIV-infected injection drug users in Vancouver, Canada, did not find an increase in sexual risk behaviors after initiation of treatment.20 An earlier paper from Uganda showed that the population had misconceptions that wider ART access could result in increased risky sexual behaviors, hence further HIV transmission.21 However, in four studies, one from Cote-d'Ivoire and three from Uganda, receiving ART was neither associated with increased sexual activity nor unprotected sex,22-24 even among HIV-uninfected household members of subjects receiving ART.25 However, these studies were cross-sectional in design or had short follow-up. A strength of this study is the long follow-up period, which allowed us to ascertain whether sexual behaviors adopted soon after initiating ART were maintained or whether patients experienced a “prevention fatigue.”10,26 A similar study from South Africa encompassing rural and urban clinics demonstrated that sexual risk behavior significantly decreased after ART initiation among HIV-infected South African men and women in primary care program.27
The low levels of awareness of partner HIV status among married individuals are a cause for concern but not an unusual finding in East Africa. Sarna and colleagues also reported that more than 40% of HIV-infected individuals in Mombasa, Kenya, were unaware of the HIV status of their regular partner.28 Fear of their partner's reaction and poor communication skills between partners have been cited as some of the reasons for low disclosure rates.29,30 Counselors need the means to assist patients to increase their self-efficacy to disclose and highlight positive outcomes of HIV status disclosure.31 However, the encouragement of patients to share their HIV status with their partners has to be balanced with the risk of violence after disclosure, particularly among women.
Although detectable plasma HIV RNA concentration in the context of ART is associated with the presence of genotypic resistance mutations,15,32 hence, a risk of transmission of drug-resistant HIV, we observed few visits in which undetectable plasma viral load was associated with unprotected sex. We attribute this to pre- and post-ART adherence counseling provided at the clinic and the continuous availability of free condoms. Nevertheless, we did find that sexual behaviors before ART initiation were strongly associated with sexual behaviors after ART initiation.
This study has several limitations. First, sexual behaviors were based on self-report and clinic counselors also served as data collectors, which may have resulted in biased responses resulting from social desirability.33 In our study, women reported having unprotected sex more often than did men with the relative reporting of this high-risk behavior increasing over the 3 years after ART initiation. This could have been the result of a social desirability bias that increased over time in men as a reaction to an accumulation of risk-reduction messages received through ongoing counseling at the clinic. Some of the difference in reporting may also be the result of the fact that men and women served by the HIV clinic represent heterogeneous populations with inherently different propensity to use protection during sexual intercourse. Also, only male condoms were made available at the clinic; thus, male partner consent and effective negotiation skills among women would be needed if they were to be used properly.34-36
A second limitation is that the nonprobability sampling of study enrollees may reduce the generalizability of our findings; however, this is unlikely because subjects were enrolled at all clinic times over a 14-month period. Moreover, sociodemographic characteristics of participants were comparable to those of larger clinic population and generally reflected individuals accessing ART in Uganda.15 Third, condom use at last (most recent) sexual intercourse may not represent one's sexual behavior over the 6 months period and provides no information on persistent risk sexual behavior but is less prone to recall bias and therefore increase the internal validity of our results.37 Finally, a significant proportion of individuals did not return for any follow-up as a result of mortality attributable to AIDS. This does not necessarily invalidate our analysis of high-risk sexual behavior because those who died may not have been sexually active. There was no evidence of differential loss to follow-up or nonrandomness in missing data. We obtained comparable results in analyses of individuals who completed all six visits and in those who completed fewer visits.
We attribute reductions in unprotected sex and multiple sexual partners to interventional effects of HIV care with ongoing counseling throughout the follow-up period.38 Findings from this study may be used as a resource in designing effective “prevention for positives” programs, maintenance of safer sexual behavior,39 and informing estimation of trends in the HIV incidence and potential spread of drug-resistant HIV.40,41 Integration of comprehensive prevention programs into HIV care is needed, particularly ones specific for women. They should include counseling clients and effective skills building to safely disclose HIV status to spouses and sexual partners and making available male and female condoms and teaching women skills in negotiating safer sex.42-47 These interventions need not to wait until ART is initiated and would be most effective in the prevention of ongoing HIV transmission if introduced at the time of HIV diagnosis or even HIV testing.
We thank study participants and the IDC cohort clinicians, Daniel Kasibante and Prossy Kayiira, for their commitment during the study.
1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-860.
2. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998;352:1725-1730.
3. Lorenz KA, Cunningham WE, Spritzer KL, et al. Changes in symptoms and health-related quality of life in a nationally representative sample of adults in treatment for HIV. Qual Life Res. 2006;15:951-958.
4. Wouters E, Heunis C, van Rensburg D, et al. Physical and emotional health outcomes after 12 months of public-sector antiretroviral treatment in the Free State Province of South Africa: a longitudinal study using structural equation modelling. BMC Public Health. 2009;9:103.
5. Spacek LA, Shihab HM, Kamya MR, et al. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Clin Infect Dis. 2006;42:252-259.
6. Wester CW, Bussmann H, Koethe J, et al. Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges. HIV Ther. 2009;3:501-526.
7. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004;18:887-895.
8. Dukers NH, Goudsmit J, de Wit JB, et al. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS. 2001;15:369-378.
9. Dilley JW, Woods WJ, McFarland W. Are advances in treatment changing views about high-risk sex? N Engl J Med. 1997;337:501-502.
10. Ostrow DE, Fox KJ, Chmiel JS, et al. Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS. 2002;16:775-780.
11. Stolte IG, Dukers NH, Geskus RB, et al. Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study. AIDS. 2004;18:303-309.
12. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA. 2004;292:224-236.
13. Martin Hilber A, Hull TH, Preston-Whyte E, et al. A cross cultural study of vaginal practices and sexuality: Implications for sexual health. Soc Sci Med. 2009;9:9.
14. Kennedy C, O'Reilly K, Medley A, et al. The impact of HIV treatment on risk behaviour in developing countries: a systematic review. AIDS Care. 2007;19:707-720.
15. Kamya MR, Mayanja-Kizza H, Kambugu A, et al. Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;46:187-193.
16. World Health Organization. Scaling Up Antiretroviral Therapy in Resource Limited Settings. Guidelines for a Public Health Approach. Geneva: WHO; 2002.
17. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702-706.
18. Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23:1397-1404.
19. Castelnuovo B, Manabe YC, Kiragga A, et al. Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort. Clin Infect Dis. 2009;49:965-972.
20. Marshall BD, Milloy MJ, Kerr T, et al. No evidence of increased sexual risk behaviour after initiating antiretroviral therapy among people who inject drugs. AIDS. 2010;24:2271-2278.
21. Atuyambe L, Neema S, Otolok-Tanga E, et al. The effects of enhanced access to antiretroviral therapy: a qualitative study of community perceptions in Kampala city, Uganda. Afr Health Sci. 2008;8:13-19.
22. Moatti JP, Prudhomme J, Traore DC, et al. Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Cote d'Ivoire. AIDS. 2003;17(Suppl 3):S69-S77.
23. Bateganya M, Colfax G, Shafer LA, et al. Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral- naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda. AIDS Patient Care STDs. 2005;19:760-768.
24. Bunnell R, Opio A, Musinguzi J, et al. HIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative survey. AIDS. 2008;22:617-624.
25. Bechange S, Bunnell R, Awor A, et al. Two-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibition. AIDS Behav. 2008;24:24.
26. Stockman JK, Schwarcz SK, Butler LM, et al. HIV prevention fatigue among high-risk populations in San Francisco. J Acquir Immune Defic Syndr. 2004;35:432-434.
27. Venkatesh KK, de Bruyn G, Lurie MN, et al. Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics. AIDS. 2010:31:2687-2696.
28. Sarna A, Luchters SM, Geibel S, et al. Sexual risk behaviour and HAART: a comparative study of HIV-infected persons on HAART and on preventive therapy in Kenya. Int J STD AIDS. 2008;19:85-89.
29. Maman S, Mbwambo JK, Hogan NM, et al. High rates and positive outcomes of HIV-serostatus disclosure to sexual partners: reasons for cautious optimism from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. AIDS Behav. 2003;7:373-382.
30. Maman S, Mbwambo J, Hogan NM, et al. Women's barriers to HIV-1 testing and disclosure: challenges for HIV-1 voluntary counselling and testing. AIDS Care. 2001;13:595-603.
31. Sullivan KM. Male self-disclosure of HIV-positive serostatus to sex partners: a review of the literature. J Assoc Nurses AIDS Care. 2005;16:33-47.
32. Hakim Sendagire BC, Kiragga A, Kambugu A, et al. CDB029-Factors Associated With Increasing HIV-1 Resistance to Antiretroviral Therapy in an Urban Cohort in Kampala, Uganda. 5th IAS Conference on HIV Pathogenesis Treatment and Prevention; Cape Town; 2009.
33. Schroder KE, Carey MP, Vanable PA. Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med. 2003;26:104-123.
34. Shannon K, Strathdee SA, Shoveller J, et al. Structural and environmental barriers to condom use negotiation with clients among female sex workers: implications for HIV-prevention strategies and policy. Am J Public Health. 2009;99:659-665.
35. Lifshay J, Nakayiwa S, King R, et al. Partners at risk: motivations, strategies, and challenges to HIV transmission risk reduction among HIV-infected men and women in Uganda. AIDS Care. 2009;29:1-10.
36. Stevens PE, Galvao L. 'He Won't Use Condoms': HIV-infected women's struggles in primary relationships with serodiscordant partners. Am J Public Health. 2007;97:1015-1022.
37. Graham CA, Crosby RA, Sanders SA, et al. Assessment of condom use in men and women. Annu Rev Sex Res. 2005;16:20-52.
38. Spire B, de Zoysa I, Himmich H. HIV prevention: what have we learned from community experiences in concentrated epidemics? J Int AIDS Soc. 2008;11:5.
39. Auerbach JD, Coates TJ. HIV prevention research: accomplishments and challenges for the third decade of AIDS. Am J Public Health. 2000;90:1029-1032.
40. Salomon JA, Hogan DR, Stover J, et al. Integrating HIV prevention and treatment: from slogans to impact. PLoS Med. 2005;2:e16.
41. Baggaley RF, Garnett GP, Ferguson NM. Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med. 2006;3:e124.
42. Anand A, Shiraishi RW, Bunnell RE, et al. Knowledge of HIV status, sexual risk behaviors and contraceptive need among people living with HIV in Kenya and Malawi. AIDS. 2009;23:1565-1573.
43. Wingood GM, DiClemente RJ, Mikhail I, et al. A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: the WiLLOW Program. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S58-S67.
44. Kalichman SC, Rompa D, Cage M, et al. Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. Am J Prev Med. 2001;21:84-92.
45. Crepaz N, Lyles CM, Wolitski RJ, et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS. 2006;20:143-157.
46. Lightfoot M, Rotheram-Borus MJ, Comulada WS, et al. Efficacy of brief interventions in clinical care settings for persons living with HIV. J Acquir Immune Defic Syndr. 2009;8:8.
47. Rotheram-Borus MJ, Swendeman D, Comulada WS, et al. Prevention for substance-using HIV-positive young people: telephone and in-person delivery. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S68-S77.
This article has been cited 4 time(s).
Journal of Infection in Developing CountriesThe impact of highly active antiretroviral therapy on high-risk behaviour of HIV-infected patients in sub-Saharan AfricaJournal of Infection in Developing Countries
AIDS Research and TherapyIs the Sexual Behaviour of HIV Patients on Antiretroviral therapy safe or risky in Sub-Saharan Africa? Meta-Analysis and Meta-RegressionAIDS Research and Therapy
AIDS Research and TherapySexual risk behaviour, marriage and ART: a study of HIV-positive people in Papua New GuineaAIDS Research and Therapy
Bmc Public HealthAlcohol use and HIV serostatus of partner predict high-risk sexual behavior among patients receiving antiretroviral therapy in South Western UgandaBmc Public Health
HIV/AIDS; antiretroviral therapy; sexual behavior; unprotected sex; condom use; positive prevention; Uganda
© 2011 Lippincott Williams & Wilkins, Inc.
Highlight selected keywords in the article text.